On‐therapy impedance‐pH monitoring can efficiently characterize PPI ‐refractory GERD and support treatment escalation
Neurogastroenterology & Motility · 2023
DOI: 10.1111/nmo.14547 ↗At a glance
Journal article in Neurogastroenterology & Motility, 2023. Written by Marzio Frazzoni and 6 co-authors. Institution: Digestive Pathophysiology Unit and Digestive Endoscopy Unit, Azienda Ospedaliero Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Ital…. Major MEDLINE topics: Heartburn, Gastroesophageal Reflux. Cited 13 times so far (Crossref); 30 references.
Abstract (original language)
Background
On‐therapy impedance‐pH monitoring is recommended in patients with documented GERD and PPI‐refractory heartburn in order to establish whether the unremitting symptom is reflux‐related or not.
Aims
To define on‐PPI cut‐offs of impedance‐pH metrics allowing proper interpretation of on‐therapy impedance‐pH monitoring.
Methods
Blinded expert review of impedance‐pH tracings performed during double‐dosage PPI, prospectively collected from 150 GERD patients with PPI‐refractory heartburn and 45 GERD patients with PPI‐responsive heartburn but persisting extra‐esophageal symptoms. Acid exposure time (AET), number of total refluxes (TRs), post‐reflux swallow‐induced peristaltic wave (PSPW) index, and mean nocturnal baseline impedance (MNBI) were assessed. On‐PPI cut‐offs were defined and evaluated with ROC analysis and the area under curve (AUC).
Results
All the four impedance‐pH metrics significantly differed between PPI‐refractory and PPI‐responsive heartburn cases. At ROC analysis, AUC was 0.73 for AET, 0.75 for TRs, 0.81 for PSPW index, and 0.71 for MNBI; best cut‐offs were ≥1.7% for AET, ≥45 for TRs, ≤36% for PSPW index, and ≤ 1847 Ω for MNBI; AUC of such cut‐offs was 0.66, 0.71, 0.73, and 0.68, respectively. Analysis of PSPW index and MNBI added to assessment of AET and TRs significantly increased the yield of on‐therapy impedance‐pH monitoring in the PPI‐refractory cohort (97% vs. 83%, p < 0.0001). Notably, suboptimal acid suppression as shown by AET ≥1.7% was detected in 43% of 150 PPI‐refractory cases.
Conclusions
We have defined on‐PPI cut‐offs of impedance‐pH metrics by which comprehensive assessment of impedance‐pH tracings, including analysis of PSPW index and MNBI can efficiently characterize PPI‐refractory GERD and support treatment escalation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Digestive Pathophysiology Unit and Digestive Endoscopy Unit, Azienda Ospedaliero Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy.
- Gastroenterology Unit, Department of Medical and Surgical Sciences, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S Orsola-Malpighi, Bologna, Italy.
- Dipartimento di Medicina e Chirurgia, Digestive Disease, Università Campus Bio-Medico di Roma, Roma, Italy.
- Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.
ORCID profiles: Marzio Frazzoni, Mentore Ribolsi, Nicola De Bortoli
Cite
APA
Frazzoni, M., Frazzoni, L., Ribolsi, M., Russo, S., Conigliaro, R., De Bortoli, N., & Savarino, E. (2023). On‐therapy impedance‐pH monitoring can efficiently characterize PPI ‐refractory GERD and support treatment escalation. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.14547
Vancouver
Frazzoni M, Frazzoni L, Ribolsi M, Russo S, Conigliaro R, De Bortoli N, et al. On‐therapy impedance‐pH monitoring can efficiently characterize PPI ‐refractory GERD and support treatment escalation. Neurogastroenterology & Motility. 2023. doi:10.1111/nmo.14547
BibTeX
@article{Frazzoni2023,
author = {Frazzoni, Marzio and Frazzoni, Leonardo and Ribolsi, Mentore and Russo, Salvatore and Conigliaro, Rita and De Bortoli, Nicola and Savarino, Edoardo},
title = {On‐therapy impedance‐pH monitoring can efficiently characterize PPI ‐refractory GERD and support treatment escalation},
journal = {Neurogastroenterology & Motility},
year = {2023},
doi = {10.1111/nmo.14547}
}
EUVIMED